Experts’ views on developments in EGFR+ NSCLC from June 2021
8 June 2021

Experts’ views on developments in EGFR+ NSCLC from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe the novel treatment paradigms for patients with EGFR mutations with advanced NSCLC
  • Evaluate the impact of latest advances in the clinical landscape for NSCLC EGFR exon 20 insertion mutations

 

Co-chairs:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)

 

more info...

EM-57446
Experts’ views on prostate cancer news from June 2021
8 June 2021

Experts’ views on prostate cancer news from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer from June 2021
  • Discuss how these new data will affect and be integrated into daily clinical practice

 

Faculty:

  • Kurt Miller (Germany)
  • Heather Payne (UK)
  • Karim Fizazi (France)
  • Oliver Sartor (USA) ...

more info...

EM-60950
Experts’ views on bladder cancer news from June 2021
11 June 2021

Experts’ views on bladder cancer news from June 2021

Learning objective:         

After watching this broadcast, participants should be able to:

  • Discuss new data in bladder cancer
  • Integrate new data into the current disease landscape

 

Faculty:

  • Alison Birtle (UK)
  • Ignacio Durán (Spain)
more info...

EM-60952
Charting the landscape for EGFR-positive NSCLC
24 September 2021

Charting the landscape for EGFR-positive NSCLC

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate developments in molecular testing for EGFRm+ NSCLC
  • Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
more info...

EM-60990
EGFR+ NSCLC in 2021: Key highlights of the year
15 December 2021

EGFR+ NSCLC in 2021: Key highlights of the year

Learning objective:         

After watching this broadcast, participants should be able to:

  • Describe key data on the diagnosis and management of patients with EGFR-positive NSCLC from 2021
  • Contextualise key learnings from 2021 into clinical practice through case study discussion and evaluation

 

Scientific Committee:

  • Matthew Krebs (UK)
  • Antonio Passaro (Italy)
more info...

EM-60991
;